WHO WE ARE

Foresee biosystems srl is a high-tech italian start-up incorporated in 2021.

Discover more

WHAT DO WE DO

We provide innovative platforms that allow for the prediction of toxicological outcomes of a drug or chemical on cellular models.

Discover more

PRODUCTS

Our products combine a patented LASER technology and Multi Electrode Arrays for the first family of in-vitro tool for chronic cardiac safety assessment.

Discover more

WHO WE ARE

Foresee biosystems srl is a start-up of the Italian Institute of Technology (IIT) incorporated in 2021.

Discover more

WHAT DO WE DO

We provide innovative platforms that allow for the prediction of toxicological outcomes of a drug or chemical on cellular models.

Discover more

PRODUCT

Our products combine a patented LASER technology and Multi Electrode Arrays for the first family of in-vitro tool for chronic cardiac safety assessment.

Discover more

Foresee Biosystems develops innovative solutions for the assessment of in-vitro cardiotoxicity.

Our products are based on a new patented LASER-based technology that allows simultaneous recordings of action potentials from thousands of cardiomyocytes, offering unprecedent electrophysiological measurements with high quality, high parallelization and extreme reliability.

Our first product, IntraCell, enables the recordings of action potentials from the same cells up to 1 month, being the first electrophysiological tool for chronic cardiotoxicity assessment.

Laser poration of beating cardiac cells cultured on MEA electrodes.

Cardiac cells are grown on MEA electrodes until they reach a confluent beating monolayer. A single fast laser pulse is applied to the MEA electrode by the operator. The extremaly low invasive approach doesn’t affect cell beating frequency, enabling accurate Action Potential recordings from the cardiomyocyte grown on the electrode.

[Melle, G., Bruno, G., Maccaferri, N., Iachetta, G., Colistra, N., Barbaglia, A., Dipalo, M., & De Angelis, F. (2020). Intracellular recording of human cardiac action potentials on market-available multielectrode array platforms. Frontiers in Bioengineering and Biotechnology].

Our advantages

FILL OUT THE FORM

FOR COMMERCIAL INFORMATION